Pharmacovigilance teams face increasing pressure to detect and report safety signals quickly and accurately. While quantitative methods like disproportionality analysis help flag potential signals, regulatory expectations now demand a thorough…
Pharmacovigilance teams face increasing pressure to detect and report safety signals quickly and accurately. While quantitative methods like disproportionality analysis…
With Artificial Intelligence (AI) in general, and Generative AI in particular becoming the next big thing in technology, we see…
Narasimha Kumar, Chief Product Officer at Datafoundry, delivered an engaging presentation titled “AI in Drug […]
The healthcare landscape is a dynamic ecosystem, constantly growing with new drugs, cosmetics, nutraceuticals, and […]
In the past few years, the domain of Pharmacovigilance (PV) (incl. Cosmetovigilance and Materiovigilance) […]
The challenges of Safety Vigilance in Pharma, Cosmetics, Devices, Vaccines and Nutraceuticals are creating a […]
Navigating the Tsunami of Data According to a recent report by Arcadia Approximately 30% of […]
The pharmaceutical industry is advancing at an unprecedented pace, with new drugs and therapies continually emerging to improve patient outcomes.…